Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
331.79
-2.04 (-0.61%)
Streaming Delayed Price
Updated: 10:35 AM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
333,685
Open
331.89
Bid (Size)
331.59 (1)
Ask (Size)
331.83 (4)
Prev. Close
333.83
Today's Range
329.98 - 333.14
52wk Range
248.38 - 346.85
Shares Outstanding
N/A
Dividend Yield
2.57%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Patchy But Still Bullish
September 02, 2024
Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.
Via
Talk Markets
Amgen Unusual Options Activity For August 29
August 29, 2024
Via
Benzinga
Performance
YTD
+11.57%
+11.57%
1 Month
+2.02%
+2.02%
3 Month
+7.93%
+7.93%
6 Month
+18.76%
+18.76%
1 Year
+30.62%
+30.62%
More News
Read More
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
August 29, 2024
Via
Investor's Business Daily
Smart Money Is Betting Big In AMGN Options
August 12, 2024
Via
Benzinga
Amgen Options Trading: A Deep Dive into Market Sentiment
August 08, 2024
Via
Benzinga
Intuit, Amgen And Sprott Uranium Miners ETF: CNBC's 'Final Trades'
August 29, 2024
Via
Benzinga
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
August 27, 2024
Via
Investor's Business Daily
Eli Lilly’s Path to the Next Trillion Market Capitalization
August 26, 2024
Via
MarketBeat
3 Unstoppable Dividend Stocks to Buy Right Now
August 25, 2024
Via
The Motley Fool
US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks
August 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ProInvestor Insights - August 2024
August 19, 2024
Via
Talk Markets
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
August 18, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the Pipeline
August 17, 2024
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations
August 15, 2024
Via
Investor's Business Daily
MarketBeat Week in Review – 8/5 - 8/9
August 10, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
August 09, 2024
Via
Investor's Business Daily
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
August 08, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
Via
The Motley Fool
Amgen's Mixed Q2 Results Highlight Obesity Drug Potential, Analysts Focus Shifts To Upcoming Clinical Readouts
August 07, 2024
Via
Benzinga
Why Amgen Stock Is Down Today Despite Solid Q2 Results
August 07, 2024
Via
The Motley Fool
Amgen Faces Near-Term Challenges But Long-Term Growth Prospects Remain Strong: Analyst
August 07, 2024
Via
Benzinga
Wall Street Poised For Second Day Of Gains While Bank Of Japan Makes Reassurances; Dollar Strengthens Against Yen, Crude Prices Surge: What's Driving Markets Wednesday?
August 07, 2024
Via
Benzinga
Amgen's MariTide Weight Loss Potential: Stock Outlook
August 07, 2024
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
August 07, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.